AstraZeneca plc (AZN) ORD USD0.25
216.00p
(1.53%)
- Add to watchlist
- Create an alert
- This stock can be held in a
216.00p
(1.53%)
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
216.00p
(1.53%)
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
14,090.00p
14,216.00p
15,730.00p
£215.50 bn
14,112.00p
13,722.65p
9,574.00p
n/a
164.00p (1.15%) Previous:
164.00p
4,172,253
1.70%
150
Performance
| 1 week 1W | 3.37% | 1 year 1Y | 17.68% |
|---|---|---|---|
| 1 month 1M | 9% | 2 years 2Y | 36.72% |
| 3 months 3M | 1.64% | 3 years 3Y | 28.79% |
| 6 months 6M | 22.93% | 5 years 5Y | 95.44% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
AstraZeneca's Calquence leukaemia treatment gets US FDA approval
20 February 2026 10:40
-
Shore Capital lowers AstraZeneca to 'hold'
13 February 2026 13:59
-
Annual sales, profits jump at AstraZeneca
10 February 2026 07:29
-
Notification of Admission of Shares
20 March 2026 11:00
-
Imfinzi approved in EU for early gastric cancer
16 March 2026 07:00
-
Notice of AGM
10 March 2026 11:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.